GAUNFACINE

GAUNFACINE was reported 3772 times

These side effects are most commonly reported by patients taking GAUNFACINE:

# Side effect Count
0 DRUG INEFFECTIVE 473
1 OFF LABEL USE 347
2 AGGRESSION 193
3 SOMNOLENCE 182
4 TOXICITY TO VARIOUS AGENTS 180
5 FATIGUE 165
6 HYPOTENSION 162
7 NAUSEA 154
8 INTENTIONAL OVERDOSE 151
9 ANXIETY 148
10 DRUG INTERACTION 139
11 HEADACHE 134
12 INSOMNIA 134
13 DIZZINESS 127
14 BRADYCARDIA 121
15 AGITATION 118
16 CONDITION AGGRAVATED 114
17 VOMITING 109
18 WEIGHT INCREASED 103
19 IRRITABILITY 102
20 PRODUCT SUBSTITUTION ISSUE 102
21 DIARRHOEA 96
22 ABNORMAL BEHAVIOUR 92
23 DEPRESSION 89
24 TREATMENT FAILURE 89
25 PRODUCT DOSE OMISSION ISSUE 88
26 PRODUCT USE IN UNAPPROVED INDICATION 88
27 DECREASED APPETITE 84
28 SEIZURE 84
29 OVERDOSE 83
30 HYPERTENSION 82
31 SUICIDAL IDEATION 82
32 RASH 76
33 ANGER 73
34 CONSTIPATION 69
35 PRODUCT USE ISSUE 67
36 ELECTROCARDIOGRAM QT PROLONGED 66
37 PSYCHOMOTOR HYPERACTIVITY 65
38 COMPLETED SUICIDE 64
39 TACHYCARDIA 63
40 FALL 61
41 LETHARGY 61
42 PRODUCT QUALITY ISSUE 61
43 ABDOMINAL PAIN UPPER 60
44 SEROTONIN SYNDROME 58
45 SUICIDE ATTEMPT 55
46 WEIGHT DECREASED 54
47 SEDATION 52
48 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 52
49 FEELING ABNORMAL 51
50 HYPERHIDROSIS 51
51 ASTHENIA 50
52 MALAISE 50
53 PAIN 50
54 PRURITUS 50
55 DISTURBANCE IN ATTENTION 49
56 SINUS BRADYCARDIA 49
57 TREMOR 48
58 NO ADVERSE EVENT 46
59 INTENTIONAL SELF-INJURY 44
60 COMA 43
61 PNEUMONIA 43
62 COUGH 42
63 DRUG DOSE OMISSION BY DEVICE 42
64 ABDOMINAL PAIN 41
65 DYSPNOEA 41
66 DYSTONIA 41
67 HALLUCINATION 41
68 LOSS OF CONSCIOUSNESS 39
69 PARAESTHESIA 39
70 TIC 39
71 BLOOD PRESSURE INCREASED 38
72 EMOTIONAL DISORDER 38
73 PYREXIA 38
74 ARTHRALGIA 37
75 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 37
76 HYPERSENSITIVITY 37
77 SLEEP DISORDER 37
78 CARDIAC ARREST 35
79 DEATH 34
80 INCORRECT DOSE ADMINISTERED 34
81 DRY MOUTH 33
82 IMPULSIVE BEHAVIOUR 33
83 MOOD SWINGS 33
84 PAIN IN EXTREMITY 33
85 ABDOMINAL DISCOMFORT 32
86 BEHAVIOUR DISORDER 32
87 DYSARTHRIA 32
88 EMOTIONAL DISTRESS 32
89 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32
90 PERIPHERAL SWELLING 32
91 WITHDRAWAL SYNDROME 32
92 DEPRESSED LEVEL OF CONSCIOUSNESS 31
93 HOSPITALISATION 31
94 CONFUSIONAL STATE 30
95 HEART RATE INCREASED 30
96 MIGRAINE 30
97 NASOPHARYNGITIS 30
98 CHEST PAIN 29
99 RESTLESSNESS 29
100 BLOOD GLUCOSE INCREASED 28
101 INJECTION SITE PAIN 28
102 MUSCLE SPASMS 28
103 RENAL FAILURE 28
104 CHRONIC KIDNEY DISEASE 27
105 DEVICE ISSUE 27
106 MANIA 27
107 PALPITATIONS 27
108 PULMONARY OEDEMA 27
109 ACUTE KIDNEY INJURY 26
110 ASTHMA 26
111 ATTENTION DEFICIT HYPERACTIVITY DISORDER 26
112 COVID-19 26
113 DEHYDRATION 26
114 DRUG INTOLERANCE 26
115 GAIT DISTURBANCE 26
116 GYNAECOMASTIA 26
117 PRODUCT DOSE OMISSION 26
118 SYNCOPE 26
119 COGNITIVE DISORDER 25
120 DEVICE BREAKAGE 25
121 ORTHOSTATIC HYPOTENSION 25
122 TREATMENT NONCOMPLIANCE 25
123 URTICARIA 25
124 BACK PAIN 24
125 DEPRESSED MOOD 24
126 DISCOMFORT 24
127 THERAPY NON-RESPONDER 24
128 ADVERSE DRUG REACTION 23
129 BRADYPNOEA 23
130 ILLNESS 23
131 INFLUENZA 23
132 URINARY TRACT INFECTION 23
133 VISION BLURRED 23
134 CHOROIDAL EFFUSION 22
135 DRUG DOSE OMISSION 22
136 DYSKINESIA 22
137 FLUSHING 22
138 GASTROINTESTINAL HAEMORRHAGE 22
139 NEUROLEPTIC MALIGNANT SYNDROME 22
140 RESPIRATORY DEPRESSION 22
141 THERAPY CESSATION 22
142 AFFECTIVE DISORDER 21
143 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 21
144 DEVICE LEAKAGE 21
145 DEVICE MECHANICAL ISSUE 21
146 ERYTHEMA 21
147 MENTAL DISORDER 21
148 BLOOD PRESSURE DECREASED 20
149 CRYING 20
150 GASTROINTESTINAL DISORDER 20
151 GENERALISED TONIC-CLONIC SEIZURE 20
152 INCREASED APPETITE 20
153 MOOD ALTERED 20
154 OEDEMA PERIPHERAL 20
155 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20
156 ACCIDENTAL OVERDOSE 19
157 CATATONIA 19
158 HALLUCINATION, AUDITORY 19
159 NEPHROGENIC DIABETES INSIPIDUS 19
160 PRODUCT ADHESION ISSUE 19
161 ADVERSE EVENT 18
162 DELIRIUM 18
163 DISTRIBUTIVE SHOCK 18
164 HYPERSOMNIA 18
165 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18
166 MACULAR DETACHMENT 18
167 PRESYNCOPE 18
168 PRODUCT PHYSICAL ISSUE 18
169 SINUSITIS 18
170 THERAPEUTIC RESPONSE DECREASED 18
171 URINARY RETENTION 18
172 AFFECT LABILITY 17
173 AMNESIA 17
174 DERMATITIS ATOPIC 17
175 DRUG EFFECT DECREASED 17
176 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 17
177 INTENTIONAL DOSE OMISSION 17
178 INTENTIONAL PRODUCT USE ISSUE 17
179 MEMORY IMPAIRMENT 17
180 NIGHTMARE 17
181 UNDERDOSE 17
182 CEREBRAL DISORDER 16
183 CHILLS 16
184 CONTUSION 16
185 DRUG WITHDRAWAL SYNDROME 16
186 HEART RATE DECREASED 16
187 INFECTION 16
188 INTENTIONAL PRODUCT MISUSE 16
189 LACTIC ACIDOSIS 16
190 OBSESSIVE-COMPULSIVE DISORDER 16
191 PRODUCT ADMINISTRATION INTERRUPTED 16
192 SELF-DESTRUCTIVE BEHAVIOUR 16
193 SINUS TACHYCARDIA 16
194 STRESS CARDIOMYOPATHY 16
195 THERAPY CHANGE 16
196 ABDOMINAL DISTENSION 15
197 DRUG LEVEL INCREASED 15
198 PRODUCT AVAILABILITY ISSUE 15
199 PSYCHOTIC DISORDER 15
200 RECALLED PRODUCT ADMINISTERED 15
201 STRESS 15
202 UNEVALUABLE EVENT 15
203 ACCIDENTAL EXPOSURE TO PRODUCT 14
204 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14
205 BLINDNESS UNILATERAL 14
206 CARDIAC FAILURE 14
207 DEVICE USE ERROR 14
208 DRUG HYPERSENSITIVITY 14
209 GASTROOESOPHAGEAL REFLUX DISEASE 14
210 IMPAIRED QUALITY OF LIFE 14
211 MUSCULAR WEAKNESS 14
212 NEPHROGENIC ANAEMIA 14
213 NEPHROLITHIASIS 14
214 PRIAPISM 14
215 RHINORRHOEA 14
216 SINUS ARREST 14
217 SURGERY 14
218 THERAPEUTIC PRODUCT EFFECT DECREASED 14
219 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 14
220 AKATHISIA 13
221 ANAEMIA 13
222 DIABETIC KETOACIDOSIS 13
223 DYSPEPSIA 13
224 DYSPHAGIA 13
225 EDUCATIONAL PROBLEM 13
226 ENCEPHALOPATHY 13
227 HALLUCINATION, VISUAL 13
228 MENTAL STATUS CHANGES 13
229 MYDRIASIS 13
230 NERVOUS SYSTEM DISORDER 13
231 PARANOIA 13
232 REBOUND EFFECT 13
233 SEDATION COMPLICATION 13
234 SPEECH DISORDER 13
235 SWELLING 13
236 SWELLING FACE 13
237 THERAPEUTIC RESPONSE UNEXPECTED 13
238 URINARY INCONTINENCE 13
239 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13
240 APPLICATION SITE ERYTHEMA 12
241 DISTRACTIBILITY 12
242 DRY SKIN 12
243 EAR INFECTION 12
244 END STAGE RENAL DISEASE 12
245 FEELING HOT 12
246 HYPOXIA 12
247 MENTAL IMPAIRMENT 12
248 MOVEMENT DISORDER 12
249 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12
250 MUSCLE RIGIDITY 12
251 NASAL CONGESTION 12
252 OBESITY 12
253 OROPHARYNGEAL PAIN 12
254 PRESCRIBED OVERDOSE 12
255 PRODUCT DISPENSING ERROR 12
256 PSORIASIS 12
257 RESPIRATORY FAILURE 12
258 THINKING ABNORMAL 12
259 VISUAL IMPAIRMENT 12
260 ALOPECIA 11
261 ANTICHOLINERGIC SYNDROME 11
262 APATHY 11
263 ARRHYTHMIA 11
264 BALANCE DISORDER 11
265 BLOOD TRIGLYCERIDES INCREASED 11
266 DEFIANT BEHAVIOUR 11
267 DEVICE DIFFICULT TO USE 11
268 DIPLOPIA 11
269 ECZEMA 11
270 ENURESIS 11
271 GENERAL PHYSICAL HEALTH DETERIORATION 11
272 HYPERTENSIVE URGENCY 11
273 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11
274 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 11
275 PALLOR 11
276 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11
277 RETCHING 11
278 SCREAMING 11
279 SELF-INJURIOUS IDEATION 11
280 SUSPECTED SUICIDE 11
281 THERAPY PARTIAL RESPONDER 11
282 UNRESPONSIVE TO STIMULI 11
283 VERTIGO 11
284 ACNE 10
285 APPLICATION SITE PRURITUS 10
286 BIPOLAR DISORDER 10
287 BRAIN FOG 10
288 CARDIAC DISORDER 10
289 CARDIAC FAILURE ACUTE 10
290 DISORIENTATION 10
291 DRUG TOLERANCE 10
292 EYE IRRITATION 10
293 FLATULENCE 10
294 FRUSTRATION TOLERANCE DECREASED 10
295 GASTROENTERITIS VIRAL 10
296 HYPOAESTHESIA 10
297 INABILITY TO AFFORD MEDICATION 10
298 INJECTION SITE REACTION 10
299 MIDDLE INSOMNIA 10
300 MYOCARDIAL INFARCTION 10
301 OEDEMA 10
302 POOR QUALITY DEVICE USED 10
303 POOR QUALITY SLEEP 10
304 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10
305 PRODUCT ADMINISTRATION ERROR 10
306 PULSELESS ELECTRICAL ACTIVITY 10
307 RENAL IMPAIRMENT 10
308 SALIVARY HYPERSECRETION 10
309 SEROUS RETINAL DETACHMENT 10
310 SKIN EXFOLIATION 10
311 THERAPEUTIC RESPONSE SHORTENED 10
312 THERAPY INTERRUPTED 10
313 VASOPLEGIA SYNDROME 10
314 ALTERED STATE OF CONSCIOUSNESS 9
315 BRONCHITIS 9
316 BRUGADA SYNDROME 9
317 CROHN^S DISEASE 9
318 DELUSION 9
319 DISSOCIATION 9
320 DROOLING 9
321 DRUG DEPENDENCE 9
322 DRUG PRESCRIBING ERROR 9
323 DYSPHEMIA 9
324 EATING DISORDER 9
325 EOSINOPHILIC OESOPHAGITIS 9
326 EPISTAXIS 9
327 EXTRA DOSE ADMINISTERED 9
328 FLUID RETENTION 9
329 HEPATIC ENZYME INCREASED 9
330 HYPERGLYCAEMIA 9
331 HYPOPROTEINAEMIA 9
332 IMMUNE THROMBOCYTOPENIC PURPURA 9
333 IMPAIRED GASTRIC EMPTYING 9
334 INSULIN RESISTANCE 9
335 INSURANCE ISSUE 9
336 MOBILITY DECREASED 9
337 NERVOUSNESS 9
338 NEUROPATHY PERIPHERAL 9
339 OPPOSITIONAL DEFIANT DISORDER 9
340 PANIC ATTACK 9
341 PRE-EXISTING CONDITION IMPROVED 9
342 PRODUCT PREPARATION ISSUE 9
343 PRODUCT TASTE ABNORMAL 9
344 PRODUCT USE COMPLAINT 9
345 RASH PRURITIC 9
346 RENAL INJURY 9
347 SHOCK 9
348 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9
349 STATUS EPILEPTICUS 9
350 SUBRETINAL FLUID 9
351 TARDIVE DYSKINESIA 9
352 THERAPEUTIC RESPONSE CHANGED 9
353 VIRAL INFECTION 9
354 ARTHRITIS 8
355 BLOOD CREATINE PHOSPHOKINASE INCREASED 8
356 BRAIN OEDEMA 8
357 CATARACT 8
358 CEREBROVASCULAR ACCIDENT 8
359 DEVICE MALFUNCTION 8
360 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8
361 DRUG EFFECT INCOMPLETE 8
362 DRUG LEVEL ABOVE THERAPEUTIC 8
363 DYSPHONIA 8
364 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8
365 ELECTROCARDIOGRAM T WAVE ABNORMAL 8
366 EXTRAPYRAMIDAL DISORDER 8
367 FEAR 8
368 FEELING JITTERY 8
369 GAIT INABILITY 8
370 HOMICIDAL IDEATION 8
371 HYPOPHAGIA 8
372 LEUKOCYTOSIS 8
373 LOGORRHOEA 8
374 MEDICATION RESIDUE PRESENT 8
375 MUSCLE TWITCHING 8
376 MYALGIA 8
377 NIGHT SWEATS 8
378 OROMANDIBULAR DYSTONIA 8
379 PRODUCT DOSE OMISSION IN ERROR 8
380 RENAL DISORDER 8
381 RESPIRATORY ARREST 8
382 RIB FRACTURE 8
383 SENSORY DISTURBANCE 8
384 THIRST 8
385 TOURETTE^S DISORDER 8
386 UPPER AIRWAY OBSTRUCTION 8
387 ABNORMAL WEIGHT GAIN 7
388 ANHEDONIA 7
389 APPLICATION SITE IRRITATION 7
390 ASPIRATION 7
391 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7
392 AUTISM SPECTRUM DISORDER 7
393 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7
394 BLISTER 7
395 BRUXISM 7
396 CARDIOGENIC SHOCK 7
397 CARDIOTOXICITY 7
398 DEVICE DELIVERY SYSTEM ISSUE 7
399 DISEASE PROGRESSION 7
400 DISTURBANCE IN SOCIAL BEHAVIOUR 7
401 DRUG EFFECT LESS THAN EXPECTED 7
402 DYSGEUSIA 7
403 FUNGAL INFECTION 7
404 GLYCOSYLATED HAEMOGLOBIN INCREASED 7
405 HEAD INJURY 7
406 HORNER^S SYNDROME 7
407 INCORRECT DOSE ADMINISTERED BY DEVICE 7
408 INJECTION SITE ERYTHEMA 7
409 INJECTION SITE PRURITUS 7
410 INJECTION SITE SWELLING 7
411 MEDICATION ERROR 7
412 MIOSIS 7
413 NEUROTOXICITY 7
414 PARALYSIS 7
415 PARKINSONISM 7
416 PARKINSON^S DISEASE 7
417 PLEURAL EFFUSION 7
418 POLLAKIURIA 7
419 POST-TRAUMATIC STRESS DISORDER 7
420 PRODUCT PRESCRIBING ISSUE 7
421 PULMONARY EMBOLISM 7
422 RASH ERYTHEMATOUS 7
423 SEXUAL DYSFUNCTION 7
424 TACHYPHRENIA 7
425 ALANINE AMINOTRANSFERASE INCREASED 6
426 ANION GAP 6
427 APHASIA 6
428 BLOOD GLUCOSE DECREASED 6
429 BUNDLE BRANCH BLOCK RIGHT 6
430 CARDIAC DYSFUNCTION 6
431 CARDIO-RESPIRATORY ARREST 6
432 CHEST DISCOMFORT 6
433 CHOROIDAL DETACHMENT 6
434 CIRCULATORY COLLAPSE 6
435 CYSTIC FIBROSIS 6
436 DERMATILLOMANIA 6
437 DERMATITIS CONTACT 6
438 DEVICE INFORMATION OUTPUT ISSUE 6
439 DEVICE PHYSICAL PROPERTY ISSUE 6
440 DISEASE RECURRENCE 6
441 DIZZINESS POSTURAL 6
442 DRUG ABUSE 6
443 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6
444 EUPHORIC MOOD 6
445 EYE SWELLING 6
446 GLOMERULAR FILTRATION RATE DECREASED 6
447 GRANDIOSITY 6
448 HYPERAMMONAEMIA 6
449 HYPERPHAGIA 6
450 HYPERTENSIVE EMERGENCY 6
451 HYPOTHERMIA 6
452 ILL-DEFINED DISORDER 6
453 INCORRECT PRODUCT ADMINISTRATION DURATION 6
454 INHIBITORY DRUG INTERACTION 6
455 INITIAL INSOMNIA 6
456 INJURY 6
457 JOINT SWELLING 6
458 LIQUID PRODUCT PHYSICAL ISSUE 6
459 PAIN OF SKIN 6
460 PRODUCT COMPLAINT 6
461 PRODUCT STORAGE ERROR 6
462 RESTLESS LEGS SYNDROME 6
463 SKIN BURNING SENSATION 6
464 SKIN DISCOLOURATION 6
465 SLEEP TERROR 6
466 SOMNAMBULISM 6
467 TINNITUS 6
468 WHITE BLOOD CELL COUNT INCREASED 6
469 ACTIVATION SYNDROME 5
470 ACUTE RESPIRATORY DISTRESS SYNDROME 5
471 ANAPHYLACTIC SHOCK 5
472 APNOEA 5
473 APPLICATION SITE PAIN 5
474 ASPARTATE AMINOTRANSFERASE INCREASED 5
475 ATRIOVENTRICULAR BLOCK COMPLETE 5
476 BLOOD CHOLESTEROL INCREASED 5
477 BLOOD POTASSIUM DECREASED 5
478 BLOOD UREA INCREASED 5
479 BLOOD URIC ACID INCREASED 5
480 BURNING SENSATION 5
481 CARDIAC ANEURYSM 5
482 CLOSTRIDIUM DIFFICILE INFECTION 5
483 CYSTITIS 5
484 DEVICE ADHESION ISSUE 5
485 DEVICE DEFECTIVE 5
486 DRUG-GENETIC INTERACTION 5
487 DRY EYE 5
488 DYSPHORIA 5
489 DYSURIA 5
490 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 5
491 EXCESSIVE EYE BLINKING 5
492 EYE DISORDER 5
493 EYE PAIN 5
494 EYE PRURITUS 5
495 FORMICATION 5
496 GRANULOCYTOPENIA 5
497 GRIMACING 5
498 HAEMORRHAGE 5
499 HAIR GROWTH ABNORMAL 5
500 HERPES ZOSTER 5
501 HOSTILITY 5
502 HOT FLUSH 5
503 HUNGER 5
504 HYPERTONIC BLADDER 5
505 HYPOGLYCAEMIA 5
506 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5
507 IMPULSE-CONTROL DISORDER 5
508 INCORRECT DRUG ADMINISTRATION DURATION 5
509 INFLAMMATION 5
510 INJECTION SITE MASS 5
511 LEFT VENTRICULAR HYPERTROPHY 5
512 LIMB DISCOMFORT 5
513 LIVER FUNCTION TEST ABNORMAL 5
514 LOWER LIMB FRACTURE 5
515 MUSCULOSKELETAL STIFFNESS 5
516 NECK PAIN 5
517 NEURALGIA 5
518 OCULAR HYPERAEMIA 5
519 ORAL PAIN 5
520 PETIT MAL EPILEPSY 5
521 PHYSICAL ASSAULT 5
522 PLATELET COUNT DECREASED 5
523 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5
524 PRESCRIBED UNDERDOSE 5
525 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5
526 PROCEDURAL PAIN 5
527 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5
528 PRODUCT FORMULATION ISSUE 5
529 REBOUND ACID HYPERSECRETION 5
530 RECTAL HAEMORRHAGE 5
531 RESPIRATORY ACIDOSIS 5
532 RESTLESS LEG AUGMENTATION SYNDROME 5
533 RHABDOMYOLYSIS 5
534 RHINOVIRUS INFECTION 5
535 SCAR 5
536 SEPSIS 5
537 SLEEP APNOEA SYNDROME 5
538 SLEEP DEFICIT 5
539 SLUGGISHNESS 5
540 STARING 5
541 STOMATITIS 5
542 SUICIDAL BEHAVIOUR 5
543 TEMPERATURE INTOLERANCE 5
544 THERAPEUTIC PRODUCT INEFFECTIVE 5
545 TRANSPLANT REJECTION 5
546 TRICHOTILLOMANIA 5
547 TRISMUS 5
548 UPPER RESPIRATORY TRACT INFECTION 5
549 VENTRICULAR FIBRILLATION 5
550 VENTRICULAR TACHYCARDIA 5
551 WHITE BLOOD CELL COUNT DECREASED 5
552 ABNORMAL DREAMS 4
553 ABNORMAL LOSS OF WEIGHT 4
554 ANAL INCONTINENCE 4
555 ANAPHYLACTIC REACTION 4
556 ANTICHOLINERGIC EFFECT 4
557 APPLICATION SITE RASH 4
558 AREFLEXIA 4
559 ARTHROPOD BITE 4
560 ATAXIA 4
561 ATRIOVENTRICULAR BLOCK 4
562 ATRIOVENTRICULAR DISSOCIATION 4
563 BLEPHAROSPASM 4
564 BLINDNESS 4
565 BLOOD LACTIC ACID INCREASED 4
566 BLOOD PROLACTIN INCREASED 4
567 BLOOD SODIUM DECREASED 4
568 BODY MASS INDEX DECREASED 4
569 BRAIN INJURY 4
570 CARPAL TUNNEL SYNDROME 4
571 CELLULITIS 4
572 COLD SWEAT 4
573 COORDINATION ABNORMAL 4
574 CRANIOCEREBRAL INJURY 4
575 CYANOSIS 4
576 DARK CIRCLES UNDER EYES 4
577 DEAFNESS 4
578 DECREASED ACTIVITY 4
579 DEEP VEIN THROMBOSIS 4
580 DISINHIBITION 4
581 DISRUPTIVE MOOD DYSREGULATION DISORDER 4
582 DRUG RESISTANCE 4
583 DRUG WITHDRAWAL SYNDROME NEONATAL 4
584 DYSSTASIA 4
585 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 4
586 ELECTROCARDIOGRAM T WAVE PEAKED 4
587 EXPIRED DEVICE USED 4
588 EXPIRED PRODUCT ADMINISTERED 4
589 EXPOSURE DURING PREGNANCY 4
590 FEELING COLD 4
591 GASTRITIS 4
592 GOUT 4
593 HAEMATOCHEZIA 4
594 HAEMOGLOBIN DECREASED 4
595 HAEMORRHOIDAL HAEMORRHAGE 4
596 HEPATIC FAILURE 4
597 HEPATITIS ACUTE 4
598 HYPERTENSIVE CRISIS 4
599 HYPOMANIA 4
600 HYPORESPONSIVE TO STIMULI 4
601 IMPAIRED WORK ABILITY 4
602 INCONTINENCE 4
603 INFLUENZA LIKE ILLNESS 4
604 INFUSION SITE ERYTHEMA 4
605 INJECTION SITE HAEMORRHAGE 4
606 INJECTION SITE URTICARIA 4
607 INTESTINAL OBSTRUCTION 4
608 JOINT INJURY 4
609 JOINT STIFFNESS 4
610 LIBIDO DECREASED 4
611 LIP SWELLING 4
612 LOCALISED INFECTION 4
613 LOSS OF LIBIDO 4
614 LUNG DISORDER 4
615 MAJOR DEPRESSION 4
616 MAST CELL ACTIVATION SYNDROME 4
617 MENSTRUAL DISORDER 4
618 METABOLIC ACIDOSIS 4
619 MOUTH ULCERATION 4
620 NEEDLE ISSUE 4
621 NEGATIVISM 4
622 NEUTROPENIA 4
623 OSTEOARTHRITIS 4
624 OVERWEIGHT 4
625 OXYGEN SATURATION DECREASED 4
626 PERIODIC LIMB MOVEMENT DISORDER 4
627 PHARYNGITIS STREPTOCOCCAL 4
628 PNEUMONIA ASPIRATION 4
629 PNEUMOTHORAX 4
630 POISONING DELIBERATE 4
631 POOR VENOUS ACCESS 4
632 PRODUCT DISPENSING ISSUE 4
633 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4
634 PRODUCT PRESCRIBING ERROR 4
635 PULMONARY HAEMORRHAGE 4
636 RASH MACULAR 4
637 RASH PAPULAR 4
638 RENAL CELL CARCINOMA 4
639 RENAL TUBULAR NECROSIS 4
640 SCOLIOSIS 4
641 SEPTIC SHOCK 4
642 SICKLE CELL ANAEMIA WITH CRISIS 4
643 SKIN IRRITATION 4
644 SOCIAL ANXIETY DISORDER 4
645 SOCIAL PROBLEM 4
646 SPINAL OPERATION 4
647 STAPHYLOCOCCAL BACTERAEMIA 4
648 STREPTOCOCCAL INFECTION 4
649 SUPRAVENTRICULAR EXTRASYSTOLES 4
650 TEARFULNESS 4
651 THROMBOCYTOPENIA 4
652 TRANSAMINASES INCREASED 4
653 TROPONIN I INCREASED 4
654 UPPER LIMB FRACTURE 4
655 WHEEZING 4
656 ABASIA 3
657 ACTIVITIES OF DAILY LIVING IMPAIRED 3
658 ACUTE RESPIRATORY FAILURE 3
659 ADHESIVE TAPE USE 3
660 AGEUSIA 3
661 AMENORRHOEA 3
662 ANGIOEDEMA 3
663 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 3
664 APPETITE DISORDER 3
665 ARTERIOSPASM CORONARY 3
666 ARTHROPATHY 3
667 ATRIAL FIBRILLATION 3
668 BACK DISORDER 3
669 BENIGN PROSTATIC HYPERPLASIA 3
670 BEZOAR 3
671 BLOOD ALBUMIN DECREASED 3
672 BLOOD CREATININE DECREASED 3
673 BLOOD POTASSIUM INCREASED 3
674 BLOOD PROLACTIN DECREASED 3
675 BLOOD TESTOSTERONE DECREASED 3
676 BLOOD THYROID STIMULATING HORMONE INCREASED 3
677 CATHETER SITE INFECTION 3
678 CHANGE IN SEIZURE PRESENTATION 3
679 CHOKING 3
680 CHORIORETINAL DISORDER 3
681 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
682 CLONIC CONVULSION 3
683 CONCUSSION 3
684 CONTRAINDICATED PRODUCT PRESCRIBED 3
685 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3
686 DEMENTIA 3
687 DEVICE DISLOCATION 3
688 DEVICE MATERIAL ISSUE 3
689 DISABILITY 3
690 DRUG ADMINISTRATION ERROR 3
691 DRUG DELIVERY SYSTEM ISSUE 3
692 DRUG DISPENSING ERROR 3
693 DRUG SCREEN FALSE POSITIVE 3
694 DRUG TOLERANCE DECREASED 3
695 DYSPNOEA EXERTIONAL 3
696 EAR PAIN 3
697 ELECTRIC SHOCK SENSATION 3
698 ELECTROCARDIOGRAM QT SHORTENED 3
699 ENDOCARDITIS 3
700 ENERGY INCREASED 3
701 ERECTILE DYSFUNCTION 3
702 EXOSTOSIS 3
703 EXPIRED DRUG ADMINISTERED 3
704 EXPOSURE VIA INGESTION 3
705 EXPOSURE VIA SKIN CONTACT 3
706 EYE MOVEMENT DISORDER 3
707 FEEDING DISORDER 3
708 FIBROMYALGIA 3
709 FLANK PAIN 3
710 FOETAL EXPOSURE DURING PREGNANCY 3
711 FOOD ALLERGY 3
712 FOOT DEFORMITY 3
713 FULL BLOOD COUNT DECREASED 3
714 GASTRIC DISORDER 3
715 GASTROINTESTINAL PAIN 3
716 GLYCOGEN STORAGE DISEASE TYPE VIII 3
717 GROWTH RETARDATION 3
718 HAEMATEMESIS 3
719 HEAD DISCOMFORT 3
720 HEREDITARY ANGIOEDEMA 3
721 HIRSUTISM 3
722 HYPERPARATHYROIDISM SECONDARY 3
723 HYPERPROLACTINAEMIA 3
724 HYPERTRICHOSIS 3
725 HYPERVENTILATION 3
726 HYPONATRAEMIA 3
727 HYPOTHYROIDISM 3
728 HYSTERECTOMY 3
729 IMPAIRED HEALING 3
730 INCREASED TENDENCY TO BRUISE 3
731 INFUSION SITE HAEMORRHAGE 3
732 INFUSION SITE PAIN 3
733 INFUSION SITE REACTION 3
734 INJECTION SITE BRUISING 3
735 INJECTION SITE RASH 3
736 IRRITABLE BOWEL SYNDROME 3
737 JOINT DISLOCATION 3
738 LEARNING DISABILITY 3
739 LEFT VENTRICULAR DYSFUNCTION 3
740 LIMB INJURY 3
741 LOW DENSITY LIPOPROTEIN INCREASED 3
742 MALABSORPTION 3
743 MATERNAL EXPOSURE DURING PREGNANCY 3
744 MENINGITIS 3
745 MENSTRUATION IRREGULAR 3
746 MICROCYTIC ANAEMIA 3
747 MUSCLE TIGHTNESS 3
748 MUSCULOSKELETAL DISCOMFORT 3
749 NEAR DEATH EXPERIENCE 3
750 NONSPECIFIC REACTION 3
751 OSTEOPENIA 3
752 PAIN IN JAW 3
753 PANCREATITIS 3
754 PARADOXICAL DRUG REACTION 3
755 PATIENT UNCOOPERATIVE 3
756 PERIPHERAL COLDNESS 3
757 PHYSICAL DISABILITY 3
758 PITUITARY TUMOUR 3
759 POLYCYSTIC OVARIAN SYNDROME 3
760 POLYDIPSIA 3
761 POST PROCEDURAL COMPLICATION 3
762 PRODUCT COMMUNICATION ISSUE 3
763 PRODUCT CONTAINER ISSUE 3
764 PRODUCT CONTAMINATION 3
765 PRODUCT DISTRIBUTION ISSUE 3
766 PRODUCT PACKAGING QUANTITY ISSUE 3
767 PRODUCT PREPARATION ERROR 3
768 PRODUCT SUPPLY ISSUE 3
769 PRODUCTIVE COUGH 3
770 PROPOFOL INFUSION SYNDROME 3
771 PRURITUS GENERALISED 3
772 PSEUDOMONAS INFECTION 3
773 PSORIATIC ARTHROPATHY 3
774 PULMONARY CONGESTION 3
775 PULMONARY FUNCTION TEST DECREASED 3
776 PULSE ABSENT 3
777 PYELOCALIECTASIS 3
778 REACTION TO EXCIPIENT 3
779 RESPIRATORY DISTRESS 3
780 RESPIRATORY RATE DECREASED 3
781 RESPIRATORY TRACT INFECTION 3
782 SENSITIVE SKIN 3
783 SINUS CONGESTION 3
784 SINUS DISORDER 3
785 SINUS OPERATION 3
786 SKIN FISSURES 3
787 SKIN LACERATION 3
788 SLEEP TALKING 3
789 SNORING 3
790 STAPHYLOCOCCAL INFECTION 3
791 SWEAT TEST ABNORMAL 3
792 SWELLING OF EYELID 3
793 SWOLLEN TONGUE 3
794 SYMPTOM MASKED 3
795 THERAPEUTIC PRODUCT EFFECT VARIABLE 3
796 TRANSIENT ISCHAEMIC ATTACK 3
797 TROPONIN INCREASED 3
798 TYPE 2 DIABETES MELLITUS 3
799 URINARY TRACT OBSTRUCTION 3
800 VAGINAL HAEMORRHAGE 3
801 VENTRICULAR DYSKINESIA 3
802 VITAMIN D DECREASED 3
803 WEIGHT FLUCTUATION 3
804 WEIGHT GAIN POOR 3
805 WRONG DOSE 3
806 ABDOMINAL PAIN LOWER 2
807 ABNORMAL UTERINE BLEEDING 2
808 ACIDOSIS 2
809 ACUTE MYELOID LEUKAEMIA 2
810 ADJUSTMENT DISORDER 2
811 ADRENAL INSUFFICIENCY 2
812 ADULTERATED PRODUCT 2
813 AGORAPHOBIA 2
814 ALLERGIC REACTION TO EXCIPIENT 2
815 AMINO ACID LEVEL INCREASED 2
816 ANION GAP ABNORMAL 2
817 ANXIETY DISORDER 2
818 AORTIC VALVE INCOMPETENCE 2
819 ASCITES 2
820 AUTOIMMUNE THYROIDITIS 2
821 BACTERIAL INFECTION 2
822 BIPOLAR I DISORDER 2
823 BLADDER SPASM 2
824 BLOOD CREATINE INCREASED 2
825 BLOOD DISORDER 2
826 BLOOD IRON DECREASED 2
827 BLOOD LOSS ANAEMIA 2
828 BLOOD PRESSURE FLUCTUATION 2
829 BLOOD PRESSURE INADEQUATELY CONTROLLED 2
830 BLOOD PRESSURE SYSTOLIC DECREASED 2
831 BLOOD THYROID STIMULATING HORMONE ABNORMAL 2
832 BODY HEIGHT DECREASED 2
833 BONE DISORDER 2
834 BREAST CANCER 2
835 BREAST DISORDER 2
836 BRIEF RESOLVED UNEXPLAINED EVENT 2
837 BRONCHIOLITIS 2
838 CARDIAC FAILURE CONGESTIVE 2
839 CARDIOMEGALY 2
840 CARDIOVASCULAR DISORDER 2
841 CATHETER SITE BRUISE 2
842 CATHETER SITE DISCOLOURATION 2
843 CATHETER SITE HAEMORRHAGE 2
844 CATHETER SITE SWELLING 2
845 CEREBRAL INFARCTION 2
846 CHOLELITHIASIS 2
847 CHOREA 2
848 CHRONIC FATIGUE SYNDROME 2
849 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2
850 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2
851 CLONUS 2
852 COELIAC DISEASE 2
853 COLITIS ULCERATIVE 2
854 COLON CANCER 2
855 COMA SCALE ABNORMAL 2
856 COMPLICATION ASSOCIATED WITH DEVICE 2
857 COMPLICATION OF DEVICE INSERTION 2
858 COMPLICATION OF DEVICE REMOVAL 2
859 CONDUCT DISORDER 2
860 CONSCIOUSNESS FLUCTUATING 2
861 CONVERSION DISORDER 2
862 CONVULSION 2
863 CORONAVIRUS INFECTION 2
864 CRANIOFACIAL FRACTURE 2
865 CUSHINGOID 2
866 CYST RUPTURE 2
867 CYSTIC FIBROSIS RELATED DIABETES 2
868 DAYDREAMING 2
869 DECREASED INTEREST 2
870 DECUBITUS ULCER 2
871 DEVELOPMENTAL DELAY 2
872 DEVICE INFUSION ISSUE 2
873 DEVICE OCCLUSION 2
874 DEVICE POWER SOURCE ISSUE 2
875 DEVICE USE ISSUE 2
876 DIABETES MELLITUS 2
877 DIABETES MELLITUS INADEQUATE CONTROL 2
878 DISORGANISED SPEECH 2
879 DRUG ADMINISTERED IN WRONG DEVICE 2
880 DRUG EFFECT DELAYED 2
881 DRUG EFFECT INCREASED 2
882 DRUG EFFECT VARIABLE 2
883 DRUG HALF-LIFE INCREASED 2
884 DRUG LEVEL BELOW THERAPEUTIC 2
885 DRUG LEVEL DECREASED 2
886 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2
887 DRUG SCREEN POSITIVE 2
888 DRUG WITHDRAWAL CONVULSIONS 2
889 DRY THROAT 2
890 DUODENAL ULCER 2
891 DYSGRAPHIA 2
892 DYSPAREUNIA 2
893 ECONOMIC PROBLEM 2
894 ELECTROENCEPHALOGRAM ABNORMAL 2
895 ELEVATED MOOD 2
896 EMBEDDED DEVICE 2
897 ENCEPHALITIS 2
898 ERYTHEMA OF EYELID 2
899 EXERCISE TOLERANCE DECREASED 2
900 EXPOSURE TO SARS-COV-2 2
901 EXPOSURE TO TOXIC AGENT 2
902 EXTRASYSTOLES 2
903 FACE INJURY 2
904 FACIAL PAIN 2
905 FAECES DISCOLOURED 2
906 FEBRILE NEUTROPENIA 2
907 FEELING DRUNK 2
908 FEELING OF BODY TEMPERATURE CHANGE 2
909 FLUID INTAKE REDUCED 2
910 FOAMING AT MOUTH 2
911 FOOT FRACTURE 2
912 FOREIGN BODY IN REPRODUCTIVE TRACT 2
913 FRUSTRATION 2
914 GALACTORRHOEA 2
915 GASTRIC ULCER 2
916 GASTROINTESTINAL HYPOMOTILITY 2
917 GASTROINTESTINAL MOTILITY DISORDER 2
918 GENDER DYSPHORIA 2
919 GENERALISED OEDEMA 2
920 GLOSSODYNIA 2
921 HAEMATOCRIT DECREASED 2
922 HAEMATOLOGICAL INFECTION 2
923 HAEMATURIA 2
924 HAEMODYNAMIC INSTABILITY 2
925 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2
926 HAEMORRHAGIC DIATHESIS 2
927 HALLUCINATIONS, MIXED 2
928 HEAD BANGING 2
929 HEAVY MENSTRUAL BLEEDING 2
930 HEPATITIS 2
931 HOSPICE CARE 2
932 HYPERCHOLESTEROLAEMIA 2
933 HYPERMETABOLISM 2
934 HYPERTHERMIA 2
935 HYPERVOLAEMIA 2
936 HYPOACUSIS 2
937 HYPOKALAEMIA 2
938 HYPOPHOSPHATAEMIA 2
939 HYPOPNOEA 2
940 ILEUS 2
941 IMMUNE SYSTEM DISORDER 2
942 IMPAIRED DRIVING ABILITY 2
943 IMPERCEPTION 2
944 INCORRECT STORAGE OF DRUG 2
945 INFUSION SITE BRUISING 2
946 INFUSION SITE EXTRAVASATION 2
947 INFUSION SITE INFECTION 2
948 INFUSION SITE PRURITUS 2
949 INJECTION SITE DISCOMFORT 2
950 INJECTION SITE EXTRAVASATION 2
951 INJECTION SITE INDURATION 2
952 INJECTION SITE VESICLES 2
953 INSULIN-LIKE GROWTH FACTOR DECREASED 2
954 INTENTION TREMOR 2
955 INTENTIONAL MISUSE OF DRUG DELIVERY SYSTEM 2
956 INTENTIONAL PRODUCT MISUSE TO CHILD 2
957 INTERMITTENT EXPLOSIVE DISORDER 2
958 INTRACRANIAL PRESSURE INCREASED 2
959 JAUNDICE 2
960 KIDNEY INFECTION 2
961 KLEPTOMANIA 2
962 LANGUAGE DISORDER 2
963 LIGAMENT SPRAIN 2
964 LIVEDO RETICULARIS 2
965 LOWER GASTROINTESTINAL HAEMORRHAGE 2
966 LYMPHADENOPATHY 2
967 MALIGNANT CATATONIA 2
968 MALNUTRITION 2
969 MANUFACTURING ISSUE 2
970 MANUFACTURING MATERIALS ISSUE 2
971 MASS 2
972 MASTICATION DISORDER 2
973 MEDICAL DEVICE SITE INFECTION 2
974 MEGACOLON 2
975 METABOLIC DISORDER 2
976 METABOLIC SYNDROME 2
977 MOANING 2
978 MOTOR DYSFUNCTION 2
979 MUCOUS STOOLS 2
980 MUSCLE CONTRACTIONS INVOLUNTARY 2
981 MUSCULOSKELETAL CHEST PAIN 2
982 MUSCULOSKELETAL PAIN 2
983 MYOCLONUS 2
984 NAIL PICKING 2
985 NEGATIVE THOUGHTS 2
986 NEOPLASM MALIGNANT 2
987 NEUROLOGICAL SYMPTOM 2
988 NEUROMYOPATHY 2
989 NO THERAPEUTIC RESPONSE 2
990 NODAL RHYTHM 2
991 OCULAR TOXICITY 2
992 ORAL PRURITUS 2
993 OROPHARYNGEAL DISCOMFORT 2
994 OSTEOPOROSIS 2
995 OTITIS MEDIA 2
996 OTORRHOEA 2
997 OXYGEN SATURATION ABNORMAL 2
998 PANCREATITIS NECROTISING 2
999 PARAESTHESIA ORAL 2